Colorectal cancer cell dormancy: An insight into pathways

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Colorectal cancer cell dormancy (CCD) is a major cause of treatment failure, leading to tumor recurrence and drug resistance.
• The molecular underpinnings of CCD and effective strategies to eradicate dormant cancer cells in colorectal cancer (CRC) are not well understood.
• Investigating dormancy mechanisms is critical for improving patient outcomes and developing novel therapeutic interventions.

Discussion:

• This editorial explores the intricate signaling pathways implicated in colorectal CCD.
• Key pathways discussed include Hippo/YAP, NANOG, HIF-1α, Notch, ERK/p38α/β/MAPK, and AKT signaling.
• Other relevant pathways such as STAT/p53 switch, Wnt, and SMAD signaling are also highlighted for their role in promoting CRC dormancy.

Key Insights:

• Identifying key dormancy regulator pathways offers potential for improved treatment strategies and overcoming drug resistance.
• Understanding dormancy mechanisms can lead to the development of predictive biomarkers for patient risk stratification.
• Targeted therapies tailored to individual dormancy profiles hold promise for advancing personalized medicine in CRC.

Outlook:

• Further research into these pathways and their modulation is essential for a comprehensive understanding of CRC dormancy.
• Elucidating dormancy mechanisms will enhance treatment efficacy and improve overall patient outcomes.
• Developing targeted therapies based on dormancy profiles could revolutionize CRC management.